Pharmaceutical Technology2h
NA-831 by Biomed Industries for Alzheimer’s Disease: Likelihood of Approval
NA-831 is under clinical development by Biomed Industries and currently in Phase III for Alzheimer’s Disease. According to GlobalData, Phase III drugs for Alzheimer’s Disease have a 12% phase ...
Health.com on MSN14h
12 Medications That Could Interact With Caffeine
Research shows that caffeine inhibits the action of some antibiotics, such as Avelox (moxifloxacin), Noroxin (norfloxacin), ...
The diseases with 100% fatality rates – from ‘laughing sickness’ to an inhereted ‘brain folding’ bug
SOME diseases are so devastating that survival is virtually impossible – with fatality rates hitting 100 per cent. Thankfully, due to modern medicine, they’re incredibly rare. The few that ...